>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC

1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC (Synonyms: LGPC, 1-Linoleoyl-2-hydroxy-sn-glycero-3-Phosphocholine, 1-Linoleoyl-2-hydroxy-sn-glycero-3-Phosphatidylcholine, PC(18:2/0:0), 18:2/0:0-PC)

Catalog No.GC46482

1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC(1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), 리소인지질은 인슐린 저항성(IR) 다낭성 난소 증후군에서 확인된 잠재적 바이오마커입니다. (PCOS).

Products are for research use only. Not for human use. We do not sell to patients.

1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC Chemical Structure

Cas No.: 22252-07-9

Size 가격 재고 수량
500 μg
US$163.00
재고 있음
1 mg
US$310.00
재고 있음
5 mg
US$1,140.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1-Linoleoyl-2-hydroxy-sn-glycero-3-PC (LGPC) is a lysophospholipid containing linoleic acid at the sn-1 position that has been found in mouse heart, lung, liver, spleen, kidney, plasma, and serum.1 Serum levels of LGPC decrease with increasing insulin resistance and dysglycemia in humans.2

1.Okudaira, M., Inoue, A., Shuto, A., et al.Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MSJ. Lipid Res.55(10)2178-2192(2014) 2.Gall, W.E., Beebe, K., Lawton, K.A., et al.α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationPLoS One5(5)e10883(2010)

리뷰

Review for 1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.